Squarepoint’s Melinta Therapeutics MLNT Stock Holding History
Bought
Maintained
Sold
Other funds holding MLNT
OH
Squarepoint's MLNT Position: Q4 2018 in Review
Squarepoint sold out of Melinta Therapeutics (MLNT) in Q4 2018, closing a stake of 5,342 shares — an estimated $106K sold.
Squarepoint first reported a position in MLNT in Q1 2018 and held it in 3 quarters. The position peaked at $127K in Q1 2018. 77 funds tracked by Wall St. Rank hold MLNT as of Q4 2018.
- Squarepoint reported no remaining Melinta Therapeutics position as of Q4 2018 after selling out during the quarter.
- Squarepoint sold 5,342 Melinta Therapeutics shares in Q4 2018, an estimated $106K.
- Squarepoint first reported a position in Melinta Therapeutics in Q1 2018 and held it in 3 quarters.
- Squarepoint's Melinta Therapeutics position peaked at $127K in Q1 2018.
- 77 funds tracked by Wall St. Rank held Melinta Therapeutics as of Q4 2018.
Based on Squarepoint's 13F filing for Q4 2018, filed 14 Feb 2019.